This information collection is a revision for a three-year period. The U.S. Food and Drug Administration (FDA) holds the National Cancer Institute (NCI), Division of Cancer Treatment and Diagnosis/Cancer Therapy Evaluation Program (NCI/DCTD/CTEP) and the Division of Cancer Prevention (DCP) responsible, as a sponsor of investigational drug trials, to assure the FDA that systems for accountability are being maintained by investigators in its clinical trials program. Data obtained from the Investigational Agent Accountability Record Forms are used to track the dispensing of investigational anticancer agents from receipt from the NCI to dispensing or administration to patients.
The latest form for Investigational Agent Accountability Record Forms in the Conduct of Investigational Trials in Cancer Treatment (NCI) expires 2022-03-31 and can be found here.
Document Name |
---|
Form and Instruction |
Form |
Form |
Form |
Supporting Statement A |
Supplementary Document |
Supplementary Document |
Supplementary Document |
Revision of a currently approved collection | 2024-09-30 | ||
Approved without change |
Revision of a currently approved collection | 2021-11-29 | |
Approved without change |
Revision of a currently approved collection | 2019-02-01 | |
Approved without change |
Revision of a currently approved collection | 2016-02-10 | |
Approved with change |
Revision of a currently approved collection | 2013-02-15 | |
Approved without change |
Existing collection in use without an OMB Control Number | 2010-01-28 | |
Withdrawn |
Existing collection in use without an OMB Control Number | 2009-09-17 | |
Improperly submitted |
Existing collection in use without an OMB Control Number | 2009-08-19 |
Federal Enterprise Architecture: Health - Health Care Services
Form 6 | Attach 5B Financial Disclosure DCP | Fillable Fileable | Form and instruction |
Form 5 | Attach 5 Financial Disclosure Form | Fillable Fileable | Form and instruction |
Review document collections for all forms, instructions, and supporting documents - including paper/printable forms.